Trial Profile
Investigation of Genetic Predictors of the Response to SSRI Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder; Panic disorder
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 26 Apr 2019 New source identified and integrated ClinicalTrials.gov: US National Institutes of Health NCT03927950
- 05 Sep 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
- 26 Jul 2011 New trial record